Koers RxElite, Inc. Other OTC
Aandelen
RXEI
US78347X1054
Farmaceutische producten
Omzet 2006 | 14,17 mln. 13,12 mln. | Omzet 2007 | 2,81 mln. 2,6 mln. | Marktkapitalisatie | 84,94 mln. 78,64 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2006 | 7 mln. 6,48 mln. | Nettowinst (verlies) 2007 | -17 mln. -15,74 mln. | EV/omzet 2006 * | - |
Nettoliquiditeiten 2006 | 789K 731K | Nettoliquiditeiten 2007 | 8,6 mln. 7,96 mln. | EV/omzet 2007 | 27,1 x |
K/w-verhouding 2006 * |
-
| K/w-verhouding 2007 |
-3,2
x | Werknemers | - |
Dividendrendement 2006 * |
-
| Dividendrendement 2007 |
-
| Vrij verhandelbaar | 68,17% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Earl E. Sullivan
CEO | Chief Executive Officer | 52 | 13-07-07 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,64% | 43,3 mld. | |
+21,25% | 22,22 mld. | |
+18,92% | 15,43 mld. | |
+53,19% | 12,72 mld. | |
-0,05% | 6,79 mld. | |
-11,11% | 6,71 mld. | |
-8,87% | 5,73 mld. | |
+14,68% | 5,5 mld. | |
+6,91% | 4,78 mld. |